TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Ustekinumab (Stelara) Healthcare at Home

Pharmaceutical products
Northern Ireland (UKN)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: BELFAST HEALTH AND SOCIAL CARE TRUST: "Ustekinumab (Stelara) Healthcare at Home". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUSTScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: BELFAST HEALTH AND SOCIAL CARE TRUST
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for BELFAST HEALTH AND SOCIAL CARE TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUST
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 Jul 2021, 16:25 BST
Last source update20 Jul 2021, 16:25 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Northern Ireland (UKN)
OCIDocds-h6vhtk-02ca45
What is being bought
Ustekinumab (Stelara) Healthcare at Home
What changed
From the official release history
  1. Status changed to complete
    20 Jul 2021, 16:25 BST
  2. Official notice release published
    20 Jul 2021, 16:25 BST
  3. Buyer information updated
    20 Jul 2021, 16:25 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Ustekinumab (Stelara) Healthcare at Home
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 Jul 2021, 16:25 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 24 Jun 2021, 00:00 BST · £950,000
Commercial outcome and competition
Awards
Healthcare at Home / Sciensus
Not published · Not published · active
Contracts
Ustekinumab (Stelara) Healthcare at Home
£950,000 · signed 24 Jun 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

BELFAST HEALTH AND SOCIAL CARE TRUST

Contracting authority GB-FTS-4486
View buyer profile

  • BELFAST HEALTH AND SOCIAL CARE TRUST
    buyer

    LISBURN ROAD, BELFAST, UKN, BT97AB
    norma.moore@belfasttrust.hscni.net

  • Belfast Health & Social Care Trust
    reviewBody

    Belfast

  • Healthcare at Home / Sciensus
    supplier

    Fifth Avenue, Centrum 100, Staffordshire, UKG2, DE14 2WS
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleUstekinumab (Stelara) is a branded patent protected medicine that is critical to patient care and service delivery. This is provided for homecare via Healthcare at Home.